IVF Limit denied for failing step therapy by UnitedHealthcare?

The UnitedHealthcare Commercial Medical Policy on Infertility Diagnosis, Treatment, and Fertility Preservation governs IVF coverage and refers medical-necessity reviews to the companion Clinical Guideline titled "Fertility Solutions Medical Necessity Clinical Guideline: Infertility." For purposes of this policy, infertility is defined as the inability to achieve a successful pregnancy due to medical, sexual, or reproductive history; failure to achieve pregnancy after 12 months of regular unprotected intercourse (or after 6 months when the female partner meets specified age or risk criteria). Prior authorization is required for IVF and related services and must be submitted via the UnitedHealthcare Provider Portal, and UHC frequently delegates fertility benefit management to Optum (Optum Fertility Solutions), so Optum-managed plans must route prior auth requests and appeals to Optum rather than standard UHC. Quantity limits depend on the member's specific benefit: some plans require Use of a Center of Excellence and apply a lifetime maximum benefit of $25,000 with a $10,000 prescription drug maximum (administered via CVS/Caremark) , while large-group, fully insured California plans are required to cover up to 3 completed oocyte (egg) retrievals and unlimited embryo transfers per plan year . The guideline restricts IVF in specified circumstances: natural cycle IVF is not indicated after 2 failed natural ART cycle attempts; fresh oocyte retrievals are not indicated when previously frozen M2 oocytes or embryos of at least BB grading quality (or genetically normal if tested) are available, although a fresh cycle is indicated when fewer than 20 previously frozen M2 oocytes are available , and additional infertility treatment such as controlled ovarian stimulation, IUI, or ART is not indicated within 6 months of tubal surgery unless additional infertility factors are identified or tubal compromise recurs . Self-injectable infertility drugs are subject to the member-specific benefit/pharmacy benefit administrator, and ART services (IVF, GIFT, ZIFT, PROST, TET) requested for reasons other than infertility are reviewed case-by-case under the member-specific benefit document.

- **Against benefit-exclusion denials in mandate states:** Cite state mandate language; for California, Health and Safety Code §1374.55 requires large group plans issued, amended, or renewed on or after January 1, 2026 to cover diagnosis and treatment of infertility including a maximum of three completed oocyte retrievals with unlimited embryo transfers per ASRM guidelines, and UnitedHealthcare designated this as a benefit standard effective July 1, 2025. - **Against discriminatory definitions of infertility:** UHC's own policy cites ASRM (2021b/2023), ACOG (2019), CDC (2024), and WHO (2022) definitions and recognizes infertility as the inability to achieve pregnancy due to medical, sexual, or reproductive history — not solely the 12-month-intercourse rule ; same-sex couples and single members qualify under this medical-history definition (further, SB 729 prohibits discrimination in coverage and ends the exclusion of LGBTQ+ people in fertility coverage ). - **Against "insufficient prior step therapy" (no IUI tried):** Per ASRM Committee Opinion on diminished ovarian reserve and per UHC's own guideline, IUI is not always required first — history of three failed IUI cycles is one trigger, "unless medically indicated to go straight" to IVF ; document tubal disease, severe male factor (TMSC <5M), advanced maternal age, or DOR (AMH <1.1 ng/mL or FSH ≥10 mIU/mL per ASRM 2020) as a medical indication to bypass IUI. - **Against denial for "embryo banking" or repeat fresh cycle:** Distinguish from banking; per UHC guideline, embryo cryopreservation is a necessary component of elective single embryo transfer and a vital component of pre-implantation genetic testing given the lag time from biopsy to result reporting , and a fresh cycle is indicated when there are fewer than 20 previously frozen M2 oocytes — submit antral follicle count, AMH, and prior-cycle yield to demonstrate the criteria are met. - **Against fertility-preservation denials for iatrogenic infertility (e.g., chemo, GAHT):** Per the Optum Fertility Solutions guideline, fertility preservation is medically necessary for individuals facing gonadotoxic treatment and is indicated for individuals about to undertake gender-affirming hormone therapy (2024 Expert Panel) ; cite ASCO 2018 fertility-preservation guideline and ASRM Ethics Committee Opinion on fertility preservation for medical indications. - **Against wrong-entity / procedural denial:** Confirm which vendor manages the benefit and resubmit; when the plan is Optum-managed, prior authorization requests and appeals must go to Optum, not standard UHC. Request peer-to-peer review with an Optum reproductive endocrinologist within 72 hours of denial. - **Against quantity-limit denials when fewer than 3 retrievals have been used:** Cite ASRM single-embryo-transfer guidance and the plan's own retrieval allowance; large-group fully insured plans must cover up to 3 completed oocyte retrievals and unlimited embryo transfers per plan year, using single embryo transfer when medically appropriate per ASRM — denials before that threshold contradict the policy.

## Why UnitedHealthcare Uses Step Therapy for IVF

Step therapy in the infertility context typically means UnitedHealthcare requires documentation that less-intensive treatments have been tried and have not resulted in pregnancy before IVF will be covered. Common step-therapy prerequisites may include a specified period of timed intercourse or intrauterine insemination (IUI) cycles, though the exact requirements depend on your plan's medical policy and any applicable state mandate. A step-therapy denial means the plan determined that the required prior steps were not documented, not completed, or not applicable in the way the appeal request characterized them.

## Why This Denial Is Appealable

Step-therapy protocols must be clinically appropriate for your specific diagnosis. If your reproductive endocrinologist determined that prior steps were medically contraindicated or futile — for example, because of a diagnosed condition that makes IUI ineffective — bypassing those steps is medically justified and the plan must consider a step-therapy override request. Additionally, many states have enacted step-therapy override laws requiring insurers to grant exceptions when a clinician certifies that the required step is contraindicated, ineffective for the patient's condition, or has already been tried. Federal employees and self-insured ERISA plans are generally not subject to state override laws, so your plan type matters.

## Your Federal Appeal Rights

• Internal appeal: ACA §2719 and ERISA §503 entitle you to a full-and-fair internal review. The deadline is on your denial notice.
• External review: After an adverse internal determination, an IRO can independently evaluate whether UHC correctly applied its step-therapy protocol. The external-review window is typically around four months. Expedited review is available when delay would seriously jeopardize health.

## Concrete Appeal Steps and Timeline

1. Obtain UHC's published infertility/IVF medical policy and identify exactly which prior-treatment steps are required. 2. Compile a chronological treatment history: every prior infertility treatment with dates, cycles, and documented outcomes. 3. Have your reproductive endocrinologist write a letter addressing each required step — either confirming completion with clinical evidence or explaining why a step was medically contraindicated or clinically futile for your specific diagnosis. 4. If applicable, cite your state's step-therapy override law by name and request a formal override determination. 5. Submit the appeal package before the deadline. UHC must respond within 30 days for pre-service standard appeals.

## Documentation to Gather

• Infertility diagnosis records with etiology clearly documented
• Chronological history of prior infertility treatments (IUI cycles, stimulation attempts) with dates and outcomes
• Prescriber letter explaining why IVF is the clinically appropriate next step and, where applicable, why required prior steps were contraindicated or already exhausted
• Any state step-therapy override statute reference, if your plan is subject to it
• Supporting clinical records (lab results, imaging) that demonstrate the clinical picture without fabricated numeric thresholds

## Criteria-Mapping Structure

List each step in UHC's step-therapy protocol verbatim. For each step, document either (a) completion with chart evidence and dates, or (b) the clinical reason the step was not required, supported by a physician statement and guideline reference. Present this as a structured table to make the reviewer's evaluation unambiguous.